Naproxen
Information
FDA Alert: Based on emerging information
from a long-term prevention trial, the risk of cardiovascular and
cerebrovascular events may increase among patients taking naproxen.
FDA will be analyzing all available information from these studies
to determine whether additional regulatory action is needed.
Back to Drug
Information
Requires the free Adobe
Acrobat Reader.
Date created: December 23, 2004, Updated
January 10, 2005 |